Neoadjuvant Immunotherapy Converts Hepatocellular Carcinoma

into Resectable Disease with Enhanced Anti-Tumor Immunity

Mark Yarchoan, MD

Professor, Oncology – Gastrointestinal Cancer, Sidney Kimmel Comprehensive

Cancer Center, Johns Hopkins University School of Medicine

Contact – Carly Jerome – cjerome@mednet.ucla.edu

Website – https://www.uclahealth.org/cancer/events

23-105 CHS